Skip to main content
letter
. 2013 Jul 3;118(3):199–200. doi: 10.3109/03009734.2013.785999

Table I.

Cases of ALS reported to EudraVigilance per 15 December 2012.

Substance ALS cases per substance
Adalimumab 13–18
Etanercept 25–31
Infliximab 20–24
Other RA-indicated chemical substance ≤ 3
Other RA-indicated biological substance ≤ 2
Other biological substance ≤ 5